Loading...
X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir
Atazanavir, which is marketed as REYATAZ, is the first human immunodeficiency virus type 1 (HIV-1) protease inhibitor approved for once-daily administration. As previously reported, atazanavir offers improved inhibitory profiles against several common variants of HIV-1 protease over those of the oth...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1951392/ https://ncbi.nlm.nih.gov/pubmed/17537865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02503-05 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|